Invited commentary: Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

Similar Items

• Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy
  by: Almog Ben‐Yaacov, et al.
  Published: (2024)
• Long‐term outcomes and survival analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei at a newly established peritoneal malignancy centre in Japan
  by: Hideaki Yano, et al.
  Published: (2024)
• Complexity of surgery and treatment burden in patients with peritoneal malignancy is not determined by addition of hyperthermic intraperitoneal chemotherapy
  by: Daniel Steffens, et al.
  Published: (2024)
• A machine learning approach for predicting textbook outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
  by: Amir Ashraf Ganjouei, et al.
  Published: (2024)
• Spontaneous regression of extensive colorectal cancer peritoneal metastases: first you see it, then you do not
  by: Samuel Pau, et al.
  Published: (2024)